00:00We did a little bit of the consumption of what was the first application of this normative,
00:12which has highlighted positive economic effects with a significant, let's say, transfer of
00:22medicines from a mode of delivery, let's say, that affects with an organizational mechanism
00:31that obviously leads, in particular, the patient to have to return twice to the pharmacy or
00:38even to obtain this medicine through, let's say, district pharmacies, to a
00:46modality or convention that therefore allows a ready availability of these medicines in
00:53front of the medical prescription in the pharmacy under the house or the pharmacy nearby. This has a
00:59very important value, especially in the case, obviously, of those parts of Italy where
01:06perhaps the sanitary presidiums are more distant and therefore this has a positive effect both in
01:13terms of maintaining therapeutic continuity, which above all on chronic disease pharmacies
01:19that have been the first object of this reclassification are the anti-diabetics,
01:25the glyptins, the category of glyptins is a category of anti-diabetics, therefore, which
01:30affect a pathology such as diabetes, which is a chronic pathology, and therefore, from this
01:37point of view, the economic impact that we have registered is a reduction of the costs
01:45for the national health service of 13 percent, of just over 13 percent, and the overall impact
01:54also with respect to the roof of the convention, I would say that in some way guaranteed, in the
02:02sense that, let's say, we record an advance with respect to the roof of the conventional pharmaceutical
02:10expenditure for the end of the year, which will always record an important advance of over
02:17600 million euros. The impact is overall positive, based on these results,
02:23the health ministry's monitoring table has ordered the Italian Pharmaceutical Agency
02:31to proceed with the identification by March 30 of this year of a new, how to say,
02:39therapeutic category that can be in some way considered for the transfer,
02:48the reclassification from APHT to A.
Comments